Mobile

A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in Hea...

Update Il y a 4 ans
Reference: EUCTR2004-001915-78

A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in Healthy Human Adult Volunteers »

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of the trial is to compare the immunogenicity of two doses 10^5 and 10^7 CFU of SC599 vaccine candidate to a placebo.

Inclusion criteria

  • Healthy Volunteers

Links